APROGEN

Welcome to the Brand page for “APROGEN”, which is offered here for Pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for immunomodulation; pharmaceutical preparations for immune-enhancing; pharmaceutical preparations for intestinal health and for the prevention and treatment of respiratory diseases; pharmaceutical preparations for digestive diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of eye diseases and conditions; medicines for the treatment of cardiovascular and cerebrovascular diseases; medicines for treating intestinal disorders; medicines for the treatment of gastrointestinal diseases; vaccines; colostral antibodies for medical purposes; antibody therapeutic preparations for medical purposes; pharmaceutical preparations, antibody for the treatment of acute respiratory distress syndrome, ards; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; anti-cancer preparations; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of auto-immune diseases;.

Its status is currently believed to be active. Its class is unavailable. “APROGEN” is believed to be currently owned by “APROGEN INC.”